A man walks on stage at MIT carrying three balloons. The balloons are a joke: one of the world's supposedly "oldest men" has three different recorded birthdays. The man is Dr. Saul Justin Newman, a demographer at UCL and Oxford, and in 2024 he won the first-ever Ig Nobel Prize in Demography for a simple, devastating observation: the regions famous for extreme human longevity are, to an uncomfortable degree, regions famous for bad paperwork.
I have spent over two decades in longevity research, and I want to be direct, because we have earned the right to be honest with each other. When a place's superlative longevity correlates with the absence of birth certificates and the presence of pension incentives, we are not measuring biology. We are measuring bookkeeping. That single sentence dismantles most of what you have been told about the Blue Zones. The rest of this essay is about what the real map looks like once you throw out the bad data — and the far more uncomfortable truth waiting underneath it.
A few months ago I wrote that the field of longevity had gone "woke" — that we had started policing language and feelings instead of confronting biology. The Blue Zones are a step in exactly that direction. They are a beautiful, comforting story: people in some sun-drenched village eat the right beans, drink the right wine, walk up the right hills, and live to 100. It makes wonderful dinner conversation. It sells books, Netflix specials, and municipal "wellness" contracts. And it is, for the most part, a myth.
Start with the boring question nobody asks: how do we actually know how old these people are? In his preprint — and I will be fair, it is a preprint, not yet peer-reviewed — Newman shows that the highest rates of reaching extreme old age are predicted not by olive oil or social cohesion, but by poverty, missing birth certificates, and, remarkably, fewer 90-year-olds. As he puts it, this is "the opposite of rational expectations." He has tracked down roughly 80% of the people on Earth claimed to be over 110, and "almost none" of them have a birth certificate.
This is not a fringe concern. It is the substrate on which a great deal of "extreme longevity" data is built.
Let me be careful, because credibility is the only currency that matters. Newman's critique lands hardest on three of the famous zones — Okinawa, Sardinia, and Ikaria — and much less on places like Loma Linda, where the Seventh-day Adventist community keeps genuinely good records. So I will scope the claim honestly.
Okinawa. The marketing tells you Okinawans live forever on purple sweet potatoes and vegetables. The Japanese government's own data says Okinawans eat the least vegetables and sweet potatoes of any prefecture in Japan and carry the highest body mass index in the country. Meanwhile, the family registers — the koseki — that would verify those ages were destroyed during the 1945 Battle of Okinawa. Missing records plus a great story is not evidence. It is folklore with a publicist.
Sardinia and the Mediterranean diet. Newman points out that the entire Mediterranean-diet narrative grew from noticing "a lot of centenarians on the books" in southern Italy — a region that actually had relatively short lifespans and notoriously poor record-keeping. Northern Italy, which lives longer, had fewer such records. He attributes the southern surplus to bad paperwork and outright fraud, noting that in 1997 some 30,000 "living" pension recipients in Italy were found to be dead.
Ikaria. When the Blue Zone studies were run, Greece was among the most overweight countries in Europe. "Emulate their lifestyle" is a strange prescription to draw from a population with a national obesity problem.
And if you think the documentation issue is trivial, recall what happened in 2010, when Japan actually went looking. The Justice Ministry found that 234,354 people listed in the registries as centenarians could not be confirmed alive. The scandal began when Tokyo's "oldest man," supposedly 111, was found mummified — dead for about three decades — while his family quietly collected his pension.
None of this is a personal attack on Dan Buettner, who is a talented journalist. But we should be clear-eyed that "Blue Zones" is a commercial brand — books, a Netflix series, a store, a meal planner, branded municipal "projects." A brand is not a biology. (In fairness, Blue Zones has published a rebuttal dismissing Newman's preprint, and you should read it too.)
Now flip the telescope around. Instead of hunting for magical villages, just rank the places where people verifiably live the longest. You do not find rustic isolation. You find money, education, and hospitals.
| City | Life expectancy (~2024) | Avg. IQ | Avg. income (GDP/capita, PPP) |
|---|---|---|---|
| Hong Kong | ~85.5 | ~107.7 | ~$75,600 |
| Macau | ~84.8 | ~106.3 | ~$126,900 |
| Zurich (Switzerland) | ~84.3 | ~101.0 | ~$95,800 |
| Singapore | ~84.2 | ~106.0 | ~$153,200 |
| Tokyo (Japan) | ~84.0 | ~106.3 | ~$54,400 |
| Seoul (South Korea) | ~83.7 | ~107.0 | ~$62,900 |
| Taipei (Taiwan) | ~81.2 | ~105.8 | ~$92,500 |
Life expectancy: HK Centre for Health Protection, Japan, South Korea, Taiwan. Income: IMF GDP per capita (PPP), 2024. IQ estimates: World Population Review, based on the Lynn/Becker dataset — which, as I say below, is contested and should be read as a rough cognitive-capital proxy, not gospel. Figures are territory-level (no city-specific data exists for IQ or income).
Read across any row and the same three things move together: long life, high measured cognition, high income. Read down the income column and you are looking at some of the richest places on the planet — Singapore and Macau clear six figures per capita. These are not isolated villages. They are the most prosperous, most educated, most heavily doctored urban societies humanity has built. And about that IQ column — I am not claiming intelligence makes you immortal, and I will say plainly that the national-IQ datasets are heavily criticized for weak sampling and poor comparability. I include it only because it points the same direction as everything else, and because the more defensible measure agrees: these same societies also top the OECD's PISA education rankings. Whether you call it IQ or schooling, the cognitive-capital story rhymes with the money story and the longevity story.
Note what I am not saying. Density is not a longevity drug — the densest places on Earth include Dhaka, Lagos, and the slums of Mumbai, and nobody is writing cookbooks about them. Density here is just a passenger riding on wealth and state capacity. The pattern is not mystical. The places that win at longevity are the places that have built the machinery — income, schooling, infrastructure, and access to advanced medicine — to keep people from dying early. Those things travel together, and none of them comes in a jar of supplements.
Here is the insight that should reorganize the entire debate, and it is the one the wellness industry will never put on a book jacket.
We all already know the floor. If you keep a reasonable diet, exercise, sleep, avoid the obvious poisons, and generally do what your mother told you — call it DYMT — you will live longer than average. None of that is in dispute, and none of it requires a Sardinian grandmother. The trouble is that DYMT, and wealth, and the best hospitals on the planet, all buy you the same thing: the full distance to a ceiling, and not one inch past it.
This is the robust, boring finding behind all the noise. The Preston curve (1975) shows life expectancy rising steeply with national income, then flattening hard. Chetty and colleagues, in JAMA in 2016, used 1.4 billion records to show the richest American men live about 15 years longer than the poorest — though, to their credit, the authors caution this is an association, not proof. So let me state the causal claim carefully, because it is the only one I actually need: wealth, education, and healthcare are not magic. They are the logistics of not dying early. They get you to the wall faster and more reliably. They do not move the wall.
And here is the part we are no longer allowed to say out loud, because it sounds like we are saying the rich deserve to live: further longevity gains, for everyone, track with wealth, education, and access to healthcare. Rather than confront that economics, the field retreats into the flattering fairy tale of the noble peasant outliving the billionaire on a diet of lentils. It is a more comfortable story. It is just not true.
Look closely at the real map and you see something the Blue Zone romance hides completely. Hong Kong, Singapore, Tokyo — unlimited money, the best medicine on Earth — and they all crowd around the same low-to-mid 80s, then stop. The human maximum still sits at 122.5, a record set by Jeanne Calment, who died in 1997. Nobody has beaten it. Not the richest country, not the healthiest city, not the most disciplined biohacker.
That is the whole story in one line: we have very nearly mastered the logistics of human lifespan, and we have barely touched the biology. The Blue Zone myth and the billionaire-biohacker fantasy are the same error wearing different clothes — both believe you can lifestyle or spend your way past a wall that is not logistical at all. It is biological. And biology, for the first time in human history, is becoming an engineering problem.
This reframes everything, including what a rational person should do. If you are already fit, screened, and doing the basics, the honest expected value of the next supplement stack or wellness retreat — the longevity tax — is close to zero. Every dollar and hour spent optimizing within the wall is a dollar not spent moving it. For investors, the asymmetry is just as stark: the entire wellness and Blue-Zone economy is monetizing the solved problem (getting people to the ceiling), while the unsolved one — moving the ceiling — is where every dollar of real return, and real human benefit, actually lives. And for the field, the scoreboard we should be watching is not life expectancy, which is logistics, but maximum and modal lifespan, which is biology — and which has not budged in a generation.
So the case for funding the science now is not optimism. It is arithmetic. We have run out of easy variables. The only lever left is the biology of aging itself — the targets that drive it, and the AI-driven tools that let us find and drug them at a pace evolution never intended. We will not reach 120 as a median by eating better. We will reach it by doing the hard, expensive, unglamorous work that almost no one is funding at the scale the problem deserves.
I have come to believe this is bigger than any single company, country, or ideology. Aging is the one adversary every human being shares, and beating it will require us to cooperate — as people, as nations, as institutions — instead of arguing about who is allowed to want it. We can keep telling ourselves comforting stories about magic villages and three-birthday centenarians, or we can sign a real certificate: one genuine extra decade, for everyone, written by science rather than by clerical error.
Longevity is not a lifestyle brand. Longevity is the ultimate virtue — the precondition for every other thing we value. The sooner we stop romanticizing the myth and start funding the biology, the sooner everyone, everywhere, gets more of the only thing none of us can buy back.
This is not investment advice, and it is not a diet plan. It is an argument for telling the truth.